Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.21.2
Significant Accounting Policies (Tables)
6 Months Ended
Jul. 31, 2021
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of cash, cash equivalents and restricted cash in the consolidated balance sheets as of the periods presented:

 

 

 

As of

 

 

 

July 31, 2021

 

 

January 31, 2021

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

18,933

 

 

$

5,856

 

Restricted cash

 

 

350

 

 

 

228

 

Total cash, cash equivalents and restricted cash

 

$

19,283

 

 

$

6,084

 

Schedule of Dilutive Securities Included from Computation of Loss Per Share

The number of common shares used in the computation of diluted net income per share for the period presented includes the effect of the following potentially outstanding common shares (in thousands):

 

 

 

For the Three Months Ended July 31, 2021

 

Restricted stock units

 

 

159

 

Deferred stock units

 

 

79

 

 

 

 

238

 

Schedule of Anti-dilutive Securities Excluded from Computation of Loss Per Share

The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been anti-dilutive:

 

 

 

 

For the Three Months

Ended July 31,

 

 

For the Six Months

Ended July 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

(Amounts in thousands)

 

 

(Amounts in thousands)

 

Stock options

 

 

1,453

 

 

 

2,314

 

 

 

1,671

 

 

 

967

 

Restricted stock units

 

 

113

 

 

 

65

 

 

 

124

 

 

 

58

 

Deferred stock units

 

 

62

 

 

 

82

 

 

 

41

 

 

 

82

 

 

 

 

1,628

 

 

 

2,461

 

 

 

1,836

 

 

 

1,108